Downregulation of Ras association domain family member 6 (RASSF6) underlies the treatment resistance of highly metastatic nasopharyngeal carcinoma cells.
Radiation and cisplatin-based chemotherapy are major treatments for nasopharyngeal carcinoma (NPC). However, a major impediment for further improving the cure rate is the development of treatment resistance with an undetermined molecular mechanism in metastatic NPC cells. Our established, highly met...
Guardado en:
Autores principales: | Ying-Ying Liang, Ming-Yuan Chen, Yi-Jun Hua, Shi Chen, Li-Sheng Zheng, Xue Cao, Li-Xia Peng, Ping Xie, Bi-Jun Huang, Rui Sun, Lin Wang, Yan-Qun Xiang, Xiang Guo, Chao-Nan Qian |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d635cbb4724b41c48bf67394b75d1c23 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel role of RASSF9 in maintaining epidermal homeostasis.
por: Chiou-Mei Lee, et al.
Publicado: (2011) -
EGFR/ARF6 regulation of Hh signalling stimulates oncogenic Ras tumour overgrowth
por: Chiswili Chabu, et al.
Publicado: (2017) -
Fructose-1,6-bisphosphate couples glycolytic flux to activation of Ras
por: Ken Peeters, et al.
Publicado: (2017) -
Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy
por: Lv SH, et al.
Publicado: (2021) -
Downregulation of RIP3 Improves the Protective Effect of ATF6 in an Acute Liver Injury Model
por: Mei-Ying Huang, et al.
Publicado: (2021)